New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes | RSS News Feed

New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes - Latest News

RSS Feed for this news: New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Trulicity ® (dulaglutide) significantly improves A1C (average blood sugar ... combination of once-weekly Trulicity and an SGLT-2 inhibitor shows significant promise in helping more people with type 2 diabetes ... read more

New Data Show Lilly's Trulicity® (dulaglutide) in Combination wi - KPTV - FOX 12

INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Trulicity ® (dulaglutide) significantly improves A1C (average blood sugar ... combination of once-weekly Trulicity and an SGLT-2 inhibitor shows significant promise in helping more people with type 2 diabetes ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us